Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up

Europace

Volumn 11, Issue 8, 2009, Pages 1041-1047

  Gillis, Anne M ^a,b   Morck, Margaret ^b   Exner, Derek V ^b   Sheldon, Robert S ^b   Duff, Henry J ^b   Mitchell, Brent L ^b   Wyse, George D ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b LIBIN CARDIOVASCULAR INSTITUTE OF ALBERTA   (Canada)

Author keywords

Antitachycardia pacing; Atrial fibrillation; Atrial pacing algorithms; Dual chamber pacing

Indexed keywords

AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SUPRAVENTRICULAR TACHYCARDIA; TREATMENT RESPONSE;

AGED; ATRIAL FIBRILLATION; CARDIAC PACING, ARTIFICIAL; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; TACHYCARDIA, VENTRICULAR; THERAPY, COMPUTER-ASSISTED;

EID: 68649118595     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup115     Document Type: Article

References (27)

1. Gillis AM, Morck M. Atrial fibrillation after DDDR pacemaker implantation. J Cardiovasc Electrophysiol 2002;13:542-7.
2. Gillis AM. Clinical trials of pacing for maintenance of sinus rhythm. J Interv Card Electrophysiol 2004;10:55-62.
3. Ellenbogen KA. Pacing therapy for prevention of atrial fibrillation. Heart Rhythm 2007;4:S84-7.
4. Ricci RP, Boriani G, Grammatico A, Santini M. Optimization of pacing algorithms to prevent and treat supraventricular tachyarrhythmias. Pacing Clin Electrophysiol 2006;29:S61-72.
5. Friedman PA, Dijkman B, Warman EN, Xia HA, Mehra R, Stanton MS et al. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients. Circulation 2001; 104:1023-8.
6. Gold MR, Adler S, Fauchier L, Haffajee C, Ip J, Kainz W et al. Impact of atrial prevention pacing on atrial fibrillation burden: primary results of the Study of Atrial Fibrillation Reduction (SAFARI) trial. Heart Rhythm 2009;6:295-301.
7. Lewalter T, Yang A, Pfeiffer D, Ruiter J, Schnitzler G, Markert T et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: results from the VIP registry. Pacing Clin Electrophysiol 2006;29:124-34.
8. Blanc JJ, De Roy L, Mansourati J, Poezevara Y, Marcon JL, Schoels W et al. Atrial pacing for prevention of atrial fibrillation: assessment of simultaneously implemented algorithms. Europace 2004;6:371-9.
9. Pürerfellner H, Ruiter JH, Widdershoven JW, Van Gelder IC, Urban L, Kirchhof CJ et al. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm. Heart Rhythm 2006;3:1164-71.
10. Mont L, Ruiz-Granell R, Martínez JG, Carmona JR, Fidalgo M, Cobo E et al. Impact of anti-tachycardia pacing on atrial fibrillation burden when added on top of preventive pacing algorithms: results of the prevention or termination (POT) trial. Europace 2008;10:28-34.
11. Gillis AM, Koehler J, Morck M, Mehra R, Hettrick DA. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Heart Rhythm 2005;2:791-6.
12. Lee MA, Weachter R, Pollak S, Kremers MS, Naik AM, Silverman R et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhyth-mias. J Am Coll Cardiol 2003;41:1926-32.
13. Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, Gervais P et al. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol 2003;42:627-33.
14. Padeletti L, Pürerfellner H, Adler SW, Waller TJ, Harvey M, Horvitz L et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14: 1189-95.
15. Camm AJ, Sulke N, Edvardsson N, Ritter P, Albers BA, Ruiter JH et al. Conventional and dedicated atrial overdrive pacing for the prevention of paroxysmal atrial fibrillation: the AF therapy study. Europace 2007;9:1107-9.
16. Kerr CR, Connolly SJ, Abdollah H, Roberts RS, Gent M, Yusuf S et al. Canadian Trial of Physiological Pacing: effects of physiological pacing during long-term follow-up. Circulation 2004;109:357-62.
17. Lamas GA, Lee KL, Sweeney MO, Silverman R, Leon A, Yee R et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Engl J Med 2002; 346:1854-62.
18. Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM et al. The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy. J Am Coll Cardiol 2000; 36:1303-9.
19. Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M et al. Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation. Am Heart J 2002;143:984-90.
20. Willems R, Morck ML, Exner DV, Rose SM, Gillis AM. Ventricular high-rate episodes in pacemaker diagnostics identify a high-risk subgroup of patients with tachy-brady syndrome. Heart Rhythm 2004;1:414-21.
21. Gillis AM. Rhythm control in atrial fibrillation: endpoints for device-based trials. Heart Rhythm 2004;1:B52-7.
22. Gillis AM, Morck M, Exner DV, Soo A, Rose MS, Sheldon RS et al. Beneficial effects of statin therapy for prevention of atrial fibrillation following DDDR pacemaker implantation. Eur Heart J 2008;29:1873- 80.
23. Israel CW, Ehrlich JR, Grönefeld G, Klesius A, Lawo T, Lemke B et al. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device. J Am Coll Cardiol 2001;38:355-63.
24. Gillis AM, Unterberg-Buchwald C, Schmidinger H, Massimo S, Wolfe K, Kavaney DJ et al. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002;40:1653-9.
25. Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932-7.
26. Sweeney MO, Bank AJ, Nsah E, Koullick M, Zeng QC, Hettrick D et al. Search AV Extension and Managed Ventricular Pacing for Promoting Atrioventricular Conduction (SAVE PACe) Trial. Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. N Engl J Med 2007;357:1000-8.
27. Hemels ME, Ruiter JH, Molhoek GP, Veeger NJ, Wiesfeld AC, Ranchor AV et al. Right atrial preventive and antitachycardia pacing for prevention of paroxysmal atrial fibrillation in patients without bradycardia: a randomized study. Europace 2008;10:306-13.